EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study

Ozge Kama Basci iD, Alihan Oral iD, Ali Kirik iD, Hacer Sen, Ihsan Solmaz iD, Ulas Serkan Topaloglu, Ismail Demir, Ahmet Dundar, Emine Binnetoglu iD, Nalan Okuroglu, Ahmet Aydin iD, Zeynep Irmak Kaya iD und 27 weitere

Diagnostics · 12.02.2026 · 16 (4) · 547

DOI: 10.3390/diagnostics16040547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 12.02.2026. Verfasst von Ozge Kama Basci und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Balikesir University, Altieylül, Balikesir 10145, Türkiye. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Non-invasive fibrosis scores are widely used for risk stratification in metabolic dysfunction-associated steatotic liver disease (MASLD); however, their performance in obese individuals remains controversial. The Fibrosis-4 (FIB-4) index is commonly recommended as a first-line tool, yet it may underestimate fibrosis risk in severe obesity. The BAST score, which incorporates metabolic and anthropometric parameters, has been proposed as an alternative. This study aimed to characterize both the degree and direction of discordance between FIB-4 and BAST in obese patients with MASLD.

Methods

This predefined secondary analysis included 2950 adults with obesity (BMI ≥ 30 kg/m2) and MASLD from the multicenter OBREDI-TR cohort. Fibrosis risk categories were assigned using standard cut-offs for FIB-4 and BAST, and agreement was assessed using weighted Cohen’s kappa. Associations among discordance patterns, obesity class, and the visceral adiposity index (VAI) were evaluated using chi-square tests and general linear models.

Results

Overall agreement between FIB-4 and BAST was very poor (κ = 0.041, p < 0.001). Discordance was observed in 22.3% of patients and increased markedly with obesity severity. In class III obesity, discordance was predominantly driven by low-risk classification according to FIB-4 despite high-risk classification according to BAST. Patients with this discordant pattern exhibited significantly higher VAI values than concordant cases (p < 0.001), independently of the study center.

Conclusions

In obese patients with MASLD, particularly those with morbid obesity, FIB-4 frequently classifies patients as low risk, while BAST identifies elevated fibrosis risk. This systematic discordance suggests that FIB-4 may underestimate fibrosis burden in the context of severe obesity and visceral adiposity, supporting the need for a phenotype-oriented, multimodal approach to fibrosis risk assessment.

Schlagwörter

Stichwörter der Autor:innen

BAST scoreFIB-4 scoreMASLDliver fibrosisobesity

Autor:innen und Institutionen

  • Department of Internal Medicine, Faculty of Medicine, Balikesir University, Altieylül, Balikesir 10145, Türkiye.
  • Department of Internal Medicine, Faculty of Medicine, Biruni University, Halkalı Street No. 99, Istanbul 34295, Türkiye.
  • Department of Internal Medicine, Diyarbakir Gazi Yasargil Education Research Hospital, Diyarbakir 21070, Türkiye.
  • Department of Internal Medicine, Kayseri City Hospital, Kayseri 38080, Türkiye.
  • Department of Internal Medicine, Bozyaka Education Research Hospital, Izmir 35170, Türkiye.
  • Department of Internal Medicine, Mardin Savur Prof. Dr. Aziz Sancar State Hospital, Savur 47860, Türkiye.

ORCID-Profile: Ozge Kama Basci, Alihan Oral, Ali Kirik, Ihsan Solmaz, Emine Binnetoglu, Ahmet Aydin, Zeynep Irmak Kaya, Aycan Acet, Osman Ozudogru, Kubilay Issever, Selcuk Yaylacı, Ugur Bayram Korkmaz, Celalettin Küçük, Kamil Konur, Aysun Isiklar, Esref Arac, Hüseyin Ali Öztürk, Sibel Ocak Serin, Nizameddin Koca, Alper Tuna Guven, Yasin Sahinturk

Zitieren

APA

Kama Basci, O., Oral, A., Kirik, A., Sen, H., Solmaz, I., Topaloglu, U. S., Demir, I., Dundar, A., Binnetoglu, E., Okuroglu, N., Aydin, A., Kaya, Z. I., Yildiz, H., Acet, A., Tazegul, G., Ozudogru, O., Issever, K., Yaylacı, S., Korkmaz, U. B., …, & Sözel, H. (2026). Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study. Diagnostics, 16(4), 547. https://doi.org/10.3390/diagnostics16040547

Vancouver

Kama Basci O, Oral A, Kirik A, Sen H, Solmaz I, Topaloglu US, et al. Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study. Diagnostics. 2026;16(4):547. doi:10.3390/diagnostics16040547

BibTeX
@article{KamaBasci2026,
  author = {Kama Basci, Ozge and Oral, Alihan and Kirik, Ali and Sen, Hacer and Solmaz, Ihsan and Topaloglu, Ulas Serkan and Demir, Ismail and Dundar, Ahmet and Binnetoglu, Emine and Okuroglu, Nalan and Aydin, Ahmet and Kaya, Zeynep Irmak and Yildiz, Hamit and Acet, Aycan and Tazegul, Gokhan and Ozudogru, Osman and Issever, Kubilay and Yaylacı, Selcuk and Korkmaz, Ugur Bayram and Oflas, Nur Duzen and Küçük, Celalettin and Konur, Kamil and Ayaz, Teslime and Isiklar, Aysun and Arac, Esref and Sumbul, Hilmi Erdem and Öztürk, Hüseyin Ali and Govez, Ali Burak and Durmus, Yusuf Usame and Onmez, Atilla and Serin, Sibel Ocak and Koca, Nizameddin and Yalcin, Nazif and Ertinmaz, Aysegul and Guven, Alper Tuna and Kok, Mehmet and Sahinturk, Yasin and Uyar, Seyit and Sözel, Hasan},
  title = {Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {547},
  doi = {10.3390/diagnostics16040547}
}
Kostenlos starten →